| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, CEO | Director | President &CEO
2 companies
Khattar Jack A. is a President, CEO at SUPN, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 41 sales.
Our model assigns Khattar Jack A. a middling insider score of 64/100, based on 34 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +15.3%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sell10b5-1 | 35,000 | $50.37 | $1,763,124.42 | -3.5% | -8.7% | - | |
| Oct 9, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 59,900 | $50.57 | $3,029,336.39 | -4.7% | +3.5% | -13.8% | |
| Oct 2, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 1,904 | $48.06 | $91,506.24 | -0.2% | +3.6% | -11.6% | |
| Oct 1, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 40,173 | $48.07 | $1,931,116.11 | -3.3% | +3.9% | -12.2% | |
| Sep 30, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 8,588 | $48.25 | $414,371.00 | -0.7% | +7.2% | -9.9% | |
| Sep 29, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 10,235 | $48.02 | $491,484.70 | -0.9% | +7.7% | -7.6% | |
| Sep 23, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 29,513 | $47.23 | $1,393,898.99 | -2.5% | +10.0% | -7.3% | |
| Sep 22, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 16,587 | $47.02 | $779,920.74 | -1.5% | +9.6% | -6.9% | |
| Sep 8, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 6,322 | $46.29 | $292,645.38 | -0.6% | +2.9% | -7.4% | |
| Sep 5, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 55,578 | $46.01 | $2,557,143.78 | -4.8% | -2.0% | -5.4% |